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Abstract
Background: In this study we used radiotelemetry to measure hemodynamic variables and
locomotor activity in conscious unrestrained male Protease-Activated Receptor 2 (PAR-2)
knockout mice in order to provide a detailed assessment of their blood pressure phenotype. In
addition we tested for an influence of PAR-2 on salt-sensitivity (8% versus 0.5% NaCl diet, 2.5
weeks) and angiotensin II-induced hypertension (1 μg Ile5-angiotensin II/kg/min versus 0.25 μl/h
saline, 2 weeks).
Results: Systolic arterial pressures of PAR-2 -/- (129 ± 1 mmHg, n = 21, P < 0.05) were statistically
higher than those of C57BL/6J (124 ± 1 mmHg, n = 33) throughout the 24 h period under baseline
conditions. Pulse pressures in PAR-2 -/- were also significantly elevated (33 ± 1 mmHg versus 30 ±
1 mmHg, P < 0.05), whereas diastolic arterial pressures were not. Heart rates in PAR-2 -/- were
not significantly different than controls, with the exception that heart rate of PAR-2 -/- was 23 beats
per min higher than controls (P < 0.001) during periods of nocturnal activity. The diurnal pattern
and intensity of locomotor activity were not found to differ between strains. A high salt diet led to
increased blood pressures, decreased heart rates, increased time spent active and decreased
intensity levels of locomotor activity. Salt-induced changes in systolic and pulse pressures in PAR-
2 -/- were less than in C57B/6J. Angiotensin II treatment increased pressures, decreased heart
rates, decreased time spent active and decreased intensity levels of activity of PAR-2 -/-, all to the
same extent as C57BL/6J. A trend of lower blood pressures during the middle period of angiotensin
II treatment period was observed in individual PAR-2 -/-.
Conclusion: The data indicated gene knockout of PAR-2 was associated with a modest change in
blood pressure phenotype. PAR-2 -/- mice exhibited moderate elevation of systolic arterial and
pulse pressures, yet no increased diastolic arterial pressure, no increased blood pressure responses
to high salt diet and a subtle difference in the time course of the blood pressure responses to
angiotensin II infusion.
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Protease-activated receptor 2 (PAR2), a 7 transmembrane
domain G protein coupled receptor, has been found to be
activated endogenously by specific serine proteases [1,2].
Supposedly, rather than by the binding of any known sol-
uble ligands in the circulation, serine proteases released
by endothelial cells and other cells during inflammation
and/or injury initiates PAR2-dependent actions that range
from endothelial-dependent vasodilation to production
of cytokines and stimulated de novo expression of adhe-
sion molecules [3]. No obvious blood pressure pheno-
types have been reported in PAR2 -/- albeit such in vivo
observations have so far been limited to anaesthetized
mice [4]. Studies have reported PAR2 -/- mice were resist-
ant to induction of inflammatory disease models includ-
ing arthritis [5,6], colitis [7], airway inflammation [8],
and vascular acute inflammation [9,10] and renal inflam-
mation [11]. On the other hand, PAR2 -/- were more sus-
ceptible to neurodegenerative inflammation [12,13] and
focal brain ischemia [14]. Still in other studies, PAR2 -/-
were no less or more affected than normal mice subjected
to endotoxemia [15] and renal ischemia reperfusion
injury [16]. To date there have been no studies in vivo
using PAR2 -/- whereby their constitutive hemodynamics
have been challenged such as in mouse models of
acquired hypertension. High salt diet feeding [17] and
angiotensin II infusions [18,19] can reveal novel patho-
physiological interactions of receptor signaling on hemo-
dynamic control of blood pressure. Serine proteinase
activities (renal kallikreins in particular) have been linked
to salt-sensitivity [20-22] and both salt- and angiotensin
II-induced hypertension have been linked separately to
pro-inflammation signalling pathways such as nuclear
factor-κB shared in common with PAR2 [23-30]. Such
findings provided a good rationale for testing the patho-
physiological interactions of PAR2 with regulation of
blood pressure during altered hemodynamic states partic-
ularly with the development of acquired hypertension.
The goals of this study were to describe the blood pressure
phenotype of conscious PAR2 -/- using radiotelemetry.
Specifically, we aimed to determine the baseline blood
pressure level of PAR2 -/-, and whether PAR2 -/- were more
salt-sensitive and/or more responsive to infusion with
angiotensin II than controls. These data were expected to
inform us about the interaction of PAR2 with blood pres-
sure regulation and provide insight into therapeutic pos-
sibilities for PAR2-targetted drugs in the future.
Methods
Ethics
All protocols were approved by the Institutional Animal
Care Committee of Memorial University in accordance
with the guidelines and principles recommended for the
use of animals in research by the Canadian Animal Care
Council.
Animals
Control mice (PAR2 +/+; C57BL/6J) and PAR2-deficient
mice (PAR2 -/-; B6.Cg-F2rl1tm1mslb/J) were purchased from
the Jackson Laboratories (Bar Harbor, ME). Except during
high-salt (HS) diet feeding, mice were fed a standard reg-
ular-salt (RS) feed containing 0.28% sodium (0.5%
NaCl), 1% calcium, 0.59% potassium and 0.93% phos-
phorus (NIH-31 autoclavable open formula mouse diet;
Zeigler Bros Inc., PA). High-salt diet containing 8% NaCl
was comprised otherwise as above (Zeigler Bros Inc., PA).
Mice were provided water ad libitum. Mice were housed
individually in air filter-topped cages in a room of the Ani-
mal Care Facility of the Health Sciences Center dedicated
to recording radiotelemetry data. The room lighting was
set to a 12 h light and 12 h dark cycle and room tempera-
ture was 20–22°C.
Experimental Protocol
Mice (males; PAR2 +/+: 10–20 weeks of age, 25–30 g; PAR2
-/-: 10–30 weeks of age, 24–30 g) were implanted with a
telemeter (TA11PA-C10, Datasciences Inc.) via the right
carotid artery [31,32] under isoflurane/oxygen anaesthe-
sia. All mice were allowed to recover from these surgeries
for 13 to 18 days prior to recording their baseline varia-
bles. For the HS challenge protocol, the BP data were
recorded by telemetry continuously for 3–9 days at base-
line and then for 18 days following the switch to experi-
mental diet (5 PAR2 +/+ and 5 PAR2 -/-). For the protocol
comparing the effect of high Ang II in each strain, baseline
recordings were made for a 4–7 day period. On Day 0 of
the Ang II infusion protocol, mice were removed from
their rooms shortly after the start of the light period and a
micro-osmotic pump (ALZET model 1002) containing
either isotonic saline (13 PAR2 +/+ and 7 PAR2 -/-) or Ang
II (15 PAR2 +/+ and 9 PAR2 -/-; 1 μg Ile5-angiotensin/kg/
min) was implanted dorsally s.c. Pump implantation
(~10–15 min) was performed using isoflurane/oxygen
anaesthesia, followed by monitoring their recovery for 4–
6 h before being returned to their home cages. BP data
sampling was then restarted ~18 h later at the start of the
next light period (day 1). According to the manufacturer's
literature provided with the product, steady state rate of
infusion was expected to be reached 12 h after implant of
micro-osmotic pumps. BP data in saline-treated and Ang
II-treated mice were recorded for 12–13 days before being
sacrificed. The proper placement of the catheter tips of
telemeters in the aortic arch were confirmed at autopsy.
Telemetry
Hemodynamic (systolic arterial pressure (SAP), diastolic
arterial pressure (DAP), heart rate (HR)) and locomotor
activity data were sampled for 3 s at 30 s intervals [32].Page 2 of 12
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sheet application designed for this purpose [33]. Data rep-
resenting the inactive state for each mouse was defined by
locomotor activity signal (Act, in arbitrary units) equal to
0 and active state was defined by Act > 0. Intensity of the
continuous activity (Act intensity) was calculated by loga-
rithmic base 10 transformation of all Act values when Act
>0. Corrections for calibration drift were applied to data
using the external pressure calibrations made at the end of
the protocol [17,32]. Unexpected electrical power failures
led to data exclusion and uneven sample sizes on several
days of the experiment. Data recorded during cage change
days (every 7 days) and day 0 of pump implants have
been excluded. Only data sets from mice characterized by
a stable 24 h MAP during the baseline recording period
and pulse pressure (PP) ≥ 20 mmHg throughout the day
were included in analyses. This criterion resulted in exclu-
sion of telemeter data from 1 PAR2 +/+ and 4 PAR2 -/-.
Regardless of the PP exclusion criterion, the recordings
from these mice typically contained data points at both
extremely high and low implausible ranges as well as peri-
ods of missing data acquisition signals, which have
become characteristics used to identify artifacts in teleme-
try data.
Data Analyses
Values reported and symbols on graphs are the means ±
standard error of the mean. For overall characterization of
phenotype, the data obtained at baseline preceding both
experimental protocols (high salt feeding and micro-
osmotic pump implants) were combined for each strain.
Linear regression analysis indicated that age did not have
an effect on baseline blood pressures or the effects of the
experimental protocols in our study. The calculations of
difference in telemetry variables during the experimental
treatments are paired to the average value of the individ-
ual mouse's baseline recordings. There are 6 parts to the
presentation of statistical analyses: 1) Comparison of the
effect of strain on 12 h light and 12 h dark telemetry vari-
ables at baseline (2 way ANOVA). 2) Comparison of the
effect of strain on 12 h light and 12 h dark variables at
baseline with matching of variables to activity level (Act =
0 or Act >0; 2 way repeated measures ANOVA). 3) Com-
parison of the effect of strain on change in variables dur-
ing HS diet (2 way repeated measures ANOVA). 4)
Comparison of the effect of treatment (high salt vs normal
salt) on variables with time (2 way repeated measures
ANOVA). 5) Comparison of the effect of strain on change
in variables during micro-osmotic pump treatments (2
way ANOVA). 6) Comparison of the effect of micro-
osmotic pump treatment on variables (2 way ANOVA).
Bonferroni post-hoc testing was used to identify differ-
ences between specific groups in the multiple compari-
sons. P < 0.05 was considered significant.
Results
Baseline hemodynamics of PAR2 -/- and PAR2 +/+ mice
Blood pressures were modestly, but significantly (P <
0.05) higher in PAR2 -/- than PAR2 +/+ mice (Figure 1,
Table 1). During the baseline period, SAP and pulse pres-
sures (PP) of PAR2 -/- were ~3–4% and ~6–10% higher,
respectively, than those of PAR2 +/+ for both 12 h dark
and 12 h light periods. These differences between strains
were independent of locomotor activity, being persistent
during periods of both activity and inactivity (Table 2). In
both strains, periods of locomotor activity were associated
with higher blood pressures (12 h light: Δ SAP = 19
mmHg, Δ DAP = 17 mmHg; 12 h dark: Δ SAP = 13 mmHg,
Δ DAP = 10 mmHg) (Table 2; P < 0.001). Differences in
diastolic pressures and HR between PAR2 -/- and PAR2 +/+
were generally slight and, with one exception (active HR
in dark period, P < 0.01) multiple comparisons between
strains were not statistically significant (Table 2). Patterns
of locomotor activity and the intensity level of activity
during the light and dark periods also did not differ
between strains (Figure 1, Table 2).
Table 1: Summary of baseline hemodynamics of PAR2 -/- and PAR2 +/+ mice.
Time Period Variable PAR2 +/+ PAR2 -/- Ratio PAR2 -/- to PAR2 +/+
12 h dark SAP (mmHg) 131 ± 1 ** 136 ± 1 1.04
DAP (mmHg) 101 ± 1 102 ± 1 1.00
PP (mmHg) 31 ± 1 * 33 ± 1 1.06
HR (beats min-1) 607 ± 6 622 ± 5 1.02
12 h light SAP (mmHg) 118 ± 1 * 122 ± 1 1.03
DAP (mmHg) 89 ± 1 89 ± 1 1.00
PP (mmHg) 29 ± 1 * 32 ± 1 1.10
HR (beats min-1) 587 ± 4 595 ± 5 1.01
Telemetry data from 12 hour light and 12 hour dark periods were obtained from 33 PAR2 +/+ and 21 PAR2 -/- mice. Values are mean ± standard 
error of mean. P values determined by multiple comparisons testing between strains during light and dark periods using 2 way ANOVA and 
Bonferroni post-hoc. *, P < 0.05; **, P < 0.01.Page 3 of 12
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Both dark and light period BP were increased by ~3–10
mmHg by the high salt diet in both PAR2 -/- and PAR2 +/+
mice relative to the normal salt diet period (Figure 2 and
Figure 3). 2 way ANOVA indicated a statistically signifi-
cant effect of strain on elevation of SAP (P < 0.05) irre-
spective of night or day during the HS diet, but differences
for specific time points were not resolved by Bonferroni
post-hoc tests. However, in contrast to our initial hypoth-
esis, the elevation of SAP by HS was less in PAR2 -/- than
in PAR2 +/+. The elevation of DAP by HS diet was not dif-
ferent between the strains. 12 h dark period pressures
remained elevated throughout the treatment period (Fig-
ure 2). In contrast, the 12 h light period pressures peaked
on the first few days of high salt and then returned to base-
line (Figure 3). Consistent with the finding of an effect of
strain on systolic, but not on diastolic pressures, 2 way
ANOVA indicated a significant effect of strain on the ele-
vation of PP by the HS diet (P < 0.05) during both night
and day, the salt-induced changes in PP being less in PAR2
-/- than in PAR2 +/+. We observed small 1–3 mmHg eleva-
tions of pulse pressures in PAR2 +/+ until day 13 of high
salt diet. A significant (~3 mmHg) difference between
strains was resolved by Bonferroni post-hoc for the 12 h
light PP difference on day 12 (Figure 3). Both strains also
exhibited similar decreased heart rates that plateaued at
~60 beats min-1 below the RS diet period around day 13
of high salt diet.
Angiotensin II effects on hemodynamics of PAR2 -/- and 
PAR2 +/+
Angiotensin II infusion had relatively similar effects on BP
in PAR2 -/- and PAR2 +/+, with systolic and diastolic pres-
sures increasing by 20–55 mmHg over the 12 d infusion
period (Figure 4 and 5). The interaction of time and treat-
ment was significant for BP variables (2 way ANOVA P <
0.05). In both strains, the rise in BP tended to be biphasic,
with an initial peak on days 1–4 being followed by a dip
in BP before it again rose during the final days of the infu-
sion. The intensity of the BP dip tended to be greater in
PAR2 -/- mice, and this effect reached significance for all
indices of BP recorded on the 7th day of infusion. How-
ever, the initial and final BP levels produced by Ang II
infusion did not differ between strains. Ang II infusion
also led to a progressive increase in PP which tended to be
greater in PAR2 -/- mice, an effect that reached statistical
significance for data obtained during the 12 h dark period
(Figure 4).
Ang II infusion was associated with similar transient
reductions in HR, Act intensity and % time spent active in
both strains. We did not observe any effect of micro-
osmotic pumps containing saline on the variables of
either strain of mouse relative to the baseline period (Fig-
ure 4 and Figure 5).
Table 2: Activity effects on hemodynamics of PAR2 -/- and PAR2 +/+ mice.
Time Period Variable PAR2 +/+ PAR2 -/- Ratio PAR2 -/- to PAR2 +/+
12 h dark % time active 52 ± 1 49 ± 2 0.96
Act intensity 1.15 ± 0.01 1.17 ± 0.02 1.02
SAP inactive (mmHg) 125 ± 1 * 128 ± 1 1.02
SAP active (mmHg) 137 ± 1 *** 142 ± 1 1.04
DAP inactive (mmHg) 95 ± 1 96 ± 1 1.01
DAP active (mmHg) 106 ± 1 109 ± 1 1.03
PP inactive (mmHg) 29 ± 1 * 33 ± 1 1.14
PP active (mmHg) 31 ± 1 * 34 ± 1 1.10
HR inactive (beats min-1) 572 ± 6 581 ± 5 1.02
HR active (beats min-1) 640 ± 6 ** 663 ± 6 1.04
12 h light % time active 28 ± 1 26 ± 1 0.93
Act intensity 1.01 ± 0.02 0.98 ± 0.02 0.97
SAP inactive (mmHg) 112 ± 1 * 117 ± 1 1.04
SAP active (mmHg) 131 ± 1 ** 136 ± 1 1.04
DAP inactive (mmHg) 84 ± 1 85 ± 1 1.01
DAP active (mmHg) 100 ± 1 102 ± 1 1.02
PP inactive (mmHg) 28 ± 1 * 32 ± 1 1.14
PP active (mmHg) 31 ± 1 * 34 ± 1 1.10
HR inactive (beats min-1) 543 ± 4 544 ± 6 1.00
HR active (beats min-1) 628 ± 4 634 ± 5 1.01
Telemetry data from 12 hour light and 12 hour dark periods were obtained from 33 PAR2 +/+ and 21 PAR2 -/- mice. Hemodynamic data were 
matched to locomotor activity status. Values are mean ± standard error of means. P values determined by multiple comparisons testing between 
strains during light and dark periods using 2 way ANOVA and Bonferroni post-hoc. *, P < 0.05; **, P < 0.01; ***, P < 0.001.Page 4 of 12
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The main findings from our study were that gene knock-
out of PAR2 was associated with only a modest change in
blood pressure phenotype. PAR-2 mice exhibited moder-
ate elevation of systolic arterial and pulse pressures, yet no
increase of diastolic arterial pressure, no increased
responses to salt and only a subtle difference on the time
course of the blood pressure responses to Ang II infusion.
We found small yet significant increases in blood pres-
sures of PAR2 -/- mice which led us to conclude their phe-
notype is characterized by moderate elevation in systolic
arterial and pulse pressures, but not diastolic arterial pres-
sures. Our telemetry data comparisons of PAR2 -/- to the
background genetic controls (C57BL/6J) provide the first
description of blood pressures and heart rates in con-
scious PAR2 -/-. Previously it was reported that the acute
hemodynamics (i.e. heart rates, blood pressures) of PAR2
-/- were not different than controls based on intracarotid
Hemodynamics and locomotor activity in PAR2 -/- and PAR2 +/+Figure 1
Hemodynamics and locomotor activity in PAR2 -/- and PAR2 +/+. Symbols are the means of variables from the 12 h 
light and 12 h dark periods in individual mice recorded via radiotelemetry during baseline periods of 2 days. The mean of each 
strain is indicated by a horizontal bar. n = 21 PAR2 -/- and 33 PAR2 +/+. * P < 0.05, PAR2 +/+ compared to PAR2 -/- using 2 way 
repeated measures ANOVA and Bonferroni post-hoc.Page 5 of 12
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Effect of high salt-diet feeding on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity during 12 h dark periodsFigure 2
Effect of high salt-diet feeding on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity during 12 h 
dark periods. Variables were measured every 30 s for 18 days via radiotelemetry during a high salt diet (8% NaCl) ad libitium. 
Symbols represent the change in means of variables over the 12 h dark periods relative to baseline feeding with a normal salt 
diet (0.4% NaCl). n = 5 in each strain. 2 way repeated measures ANOVA indicated a significant difference (P < 0.05) for systolic 
and pulse pressures between PAR2 -/- and PAR2 +/+.
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Effect of high salt-diet feeding on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity during 12 h light periodsFigure 3
Effect of high salt-diet feeding on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity during 12 h 
light periods. Variables were measured every 30 s for 18 days via radiotelemetry during a high salt diet (8% NaCl) ad libitium. 
Symbols represent the change in means of variables over the 12 h light periods relative to baseline feeding with a normal salt 
diet (0.4% NaCl). n = 5 in each strain. 2 way repeated measures ANOVA indicated a significant difference (P < 0.05) for systolic 
and pulse pressures between PAR2 -/- and PAR2 +/+.* P < 0.05, PAR2 -/- Ang II compared to PAR2 +/+ Ang II, 2 way ANOVA 
and Bonferroni post-hoc test.
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Effect of angiotensin II and saline infusions on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity during 12 h dark periodsFigure 4
Effect of angiotensin II and saline infusions on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity 
during 12 h dark periods. Variables were measured every 30 s for 13 days via radiotelemetry during infusion s.c. with angi-
otensin II (1 μg/kg/min) or isotonic saline (0.5 μl/h). Symbols represent the change in means of variables averaged over 12 h 
dark periods relative to baseline periods prior to implant of micro-osmotic pumps. Data obtained from 13 PAR2 +/+ saline, 15 
PAR2 +/+ Ang II, 7 PAR2 -/- saline and 9 PAR2 -/- Ang II. * P < 0.05, PAR2 -/- Ang II compared to PAR2 +/+ Ang II using 2 way 
ANOVA and Bonferroni post-hoc. # P < 0.05, Ang II-treated PAR2 +/+ and PAR2 -/- versus saline-treated groups, 2 way 
ANOVA and Bonferroni post-hoc test.
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Effects of angiotensin II and saline infusions on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity during 12 h light periodsFigure 5
Effects of angiotensin II and saline infusions on PAR2 -/- versus PAR2 +/+ hemodynamics and locomotor activity 
during 12 h light periods. Variables were measured every 30 s for 13 days via radiotelemetry during infusion s.c. with angi-
otensin II (1 μg/kg/min) or isotonic saline (0.5 μl/h). Symbols represent the change in means of variables averaged over 12 h 
light periods relative to baseline periods prior to implant of micro-osmotic pumps. Data obtained from 13 PAR2 +/+ saline, 15 
PAR2 +/+ Ang II, 7 PAR2 -/- saline and 9 PAR2 -/- Ang II. * P < 0.05, PAR2 -/- Ang II compared to PAR2 +/+ Ang II using 2 way 
ANOVA and Bonferroni post-hoc. # P < 0.05, Ang II-treated PAR2 +/+ and PAR2 -/- versus saline-treated groups, 2 way 
ANOVA and Bonferroni post-hoc test.
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lemetry approach for blood pressure phenotyping in con-
scious unrestrained PAR2 -/- mice, we resolved a very small
difference in hemodynamic variables. The magnitude of
these differences were so small that the physiological
impact may at first glance be considered inconsequential
under baseline conditions and further dissection of its
nature would appear to be unfeasible. Nevertheless the
use of telemetry methodology allows us to conclude with
a high degree of confidence that these subtle differences
are in fact real effects of PAR2 -/-, being observed consist-
ently in freely behaving conscious mice without the limi-
tations that may be imposed by other methods (e.g.
anesthetics, restraint, tail warming). Telemetry has been
shown to be the most accurate of current techniques avail-
able for assessing BP in rodents and has received recom-
mendation as the gold standard method for quantifying
the BP phenotype in experimental animals [34]. We also
made use of an advantage of radiotelemetrically acquired
data to assess interactions between independent variables
in order to explain the overall physiological phenotype.
For example, analyses of the radiotelemetry data has the
ability to dissect the indirect influence of genotype on
hemodynamic variables that may arise as a consequence
of behavioural changes occurring in the gene knockout.
Locomotor activity changes resulting from an abnormal
behaviour (hyperactivity) can result in changes to the dis-
tribution pattern of hemodynamic variables because con-
scious blood pressure in mice has been shown to be
strongly influenced by locomotor activity [31,32]. No
other method would likely have identified the small, but
significant increase in HR of PAR2 -/- while active at night.
We found that HR in PAR2 -/- were relatively the same as
PAR2 +/+ except during activity episodes at night. Differ-
ences in HR of PAR2 -/- and PAR2 +/+ during activity of the
dark period coincided with similarly raised intensity levels
of activity in the dark period (Table 2) which is usual for
nocturnal animals. The significance of these findings is
unknown, but could reflect a subtle effect of PAR2 -/- on
autonomic nervous system reactivity or exercise intoler-
ance.
Slightly higher PP in PAR2 -/- than in PAR2 +/+ could indi-
cate reduced endothelial-derived vasodilator tone,
reduced central arterial compliance resulting from mor-
phological and composition changes of blood vessel walls
(e.g. increased wall thickness, reduced internal diameters,
collagen deposition) and/or increased cardiac stroke vol-
umes in PAR2 -/-. Activation of PAR2 has numerous effects
including endothelium-dependent vasodilation [32,35-
38], so an elevated peripheral resistance in knockouts
would be consistent with a subtle role played by PAR2 in
modulating vascular tone. Endothelial NO synthase
(eNOS) is considered a major modulator of peripheral
resistance and the 24 h mean blood pressures of eNOS -/-
mice were found to increase by ~15% relative to controls
when measured by radiotelemetry [31]. The BP elevation
observed for PAR2 -/- mice in the present study amounts
to approximately one fourth of this level. Such differences
in BP may be reduced by compensations from the time of
conception so could explain the small size of effect of
PAR2 -/- on baseline hemodynamics in mice even if PAR2
was a critical enzyme in blood pressure regulation. Theo-
retically, the small impact on BP could also underestimate
the role played by PAR2 in modulating peripheral resist-
ance (if cardiac output decreased in knockouts as part of
compensation) or regulating local blood flow distribu-
tion.
For PAR2 to interact pathophysiologically with blood
pressure control during high salt diet loading, there
should be enzymes that mediate its activation that are
linked to blood pressure regulation. The human kal-
likreins family of serine proteinases consists of several iso-
forms that have been found to activate PAR2 [39]. It was
reported that renal kallikrein activity decreased in salt-sen-
sitive hypertensive animals and renal excretion of kal-
likreins was increased by angiotensin II [20,21,40,41].
The majority of kallikreins biological actions are mediated
through kinins, interaction with thrombin generation and
the coagulation-cascade. However, the presence of resid-
ual non-kinin effects on blood pressure regulation by
renal kallikreins during salt-loading has provided evi-
dence of additional substrates [42]. In the current study
we had hypothesized that PAR2 was one such substrate. As
a possible contributor to the mechanism of residual blood
pressure lowering activity by kallikreins during salt load-
ing, we had expected that PAR2 -/- would have been more
salt-sensitive relative to controls, but these mice were in
fact less salt sensitive than controls. Even so, the impact of
such small absolute differences in the salt-sensitivity of BP
between PAR2 -/- and PAR2 +/+ would likely to be physio-
logically trivial, and suggests that PAR2 is unlikely to play
a significant role in the regulation of salt balance. In both
strains HR was lowered during HS diet, an observation
that has been reported in humans [43]. The data do not
exclude PAR2 interaction with non-blood pressure actions
of HS diet that remain to be investigated.
In addition to HS diet, a condition where the renin-Ang II
system would be downregulated, we also treated mice
with Ang II infusion in order to investigate possible inter-
action with PAR2 on high Ang II acquired hypertension. At
the end of 2 weeks, the effects of Ang II on BP were similar
in PAR2 -/- and PAR2 +/+ mice. Collating the findings of
classic physiology studies in multiple model systems, we
expect that the immediate effects of elevating Ang II
involve central nervous system and sympathetic nervous
system activations and increases in peripheral resistancePage 10 of 12
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resetting of kidney function and remodeling of the vascu-
lature. Increasingly often there have been studies that
have sought out links between inflammation and hyper-
tension development involving angiotensin II. Studies to
induce inflammatory responses in PAR2 -/- have resulted
in mixed findings about pathological outcomes and our
data support a main finding of a null effect on Ang II-
acquired hypertension. Chronic high dose Ang II infu-
sions over the period used in this study were shown to
result in production of signs of vascular inflammation
and endothelial dysfunction by the end-point, but have
not been studied at the early time point (~7 day) at which
we observed consistent differences in the trend for hemo-
dynamic changes of PAR2 -/- [18,19]. We did not rule out
the possibility that different results might be obtained in
females. While a major interaction between Ang II and
PAR2 appears inconsequential to BP in the long term,
other pathological effects of high Ang II that arise inde-
pendent of BP such as endothelial dysfunction or the
effects of threshold BP changes by a lower dose of Ang II
could be manifested differently in PAR2 -/-. Other charac-
teristics of endothelium-dependent inflammatory
responses which have been shown to be different have
included the time to onset which was delayed in PAR2 -/-
[9] and both leukocyte adhesion and neointima forma-
tion, which were reduced in PAR2 -/-[10].
In conclusion, PAR2 -/- mice exhibited a BP phenotype
which was characterized by modest increases of systolic
arterial and pulse pressures. The BP of PAR2 -/- is not more
salt-sensitive than that of wild type mice, but differences
in the time course of the BP responses to Ang II in PAR2 -
/- and PAR2 +/+ may indicate the presence of a subtle
influence of PAR2 on Ang II modulation of BP.
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